Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Oogenesis01:22

Oogenesis

Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proceedings of the 1st European Ovary Workshop (EOW 2025) Lagos, Portugal - February 17-20, 2025.

Molecular human reproduction·2026
Same author

Cost-effectiveness of infertility treatment pathways in PCOS: where does oocyte in-vitro maturation fit?

Journal of assisted reproduction and genetics·2026
Same author

Can oral dydrogesterone mitigate adverse outcomes with low progesterone on transfer day in natural-cycle frozen embryo transfer?

Reproductive biomedicine online·2026
Same author

Dydrogesterone versus micronized vaginal progesterone for luteal phase support in artificial cycle frozen embryo transfer (REMODEL): a pilot prospective randomized controlled trial.

Frontiers in endocrinology·2026
Same author

Managing suspected endometrial polyps during IVF/ICSI stimulation: retrospective cohort study of fresh versus freeze-all strategies.

Reproductive biomedicine online·2026
Same author

Developing anti-Müllerian hormone as an ovarian reserve biomarker.

Molecular human reproduction·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

Primary ovarian insufficiency.

Michel De Vos1, Paul Devroey, Bart C J M Fauser

  • 1Centre for Reproductive Medicine, UZ Brussel, Brussels, Belgium. mdevos@uzbrussel.be

Lancet (London, England)
|August 17, 2010
PubMed
Summary
This summary is machine-generated.

Primary ovarian insufficiency (POI) is ovarian dysfunction due to ovarian causes, often leading to premature follicle exhaustion. Diagnosis involves elevated FSH and low estradiol, impacting reproductive health and fertility.

More Related Videos

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Related Experiment Videos

Last Updated: Jun 10, 2026

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Area of Science:

  • Reproductive Endocrinology
  • Genetics
  • Oncology

Background:

  • Primary ovarian insufficiency (POI) is a condition characterized by the ovary's inability to function normally.
  • It often results from premature exhaustion of the ovarian follicle reserve due to unknown mechanisms.
  • Causes can include genetic factors, medical treatments like chemotherapy or radiotherapy, and surgical interventions.

Purpose of the Study:

  • To define primary ovarian insufficiency (POI) and its underlying causes.
  • To outline diagnostic criteria for POI.
  • To discuss the reproductive and long-term health implications of POI.

Main Methods:

  • Review of existing literature on primary ovarian insufficiency.
  • Analysis of diagnostic markers including follicle-stimulating hormone (FSH) and estradiol levels.
  • Examination of the impact of POI on fertility and overall female health.

Main Results:

  • POI is diagnosed by absent menstrual cycles and confirmed by elevated serum FSH and decreased estradiol.
  • The condition frequently leads to sterility, significantly affecting reproductive health, especially in young individuals.
  • Long-term estrogen deficiency poses risks to bone density, cardiovascular health, neurological function, and general well-being.

Conclusions:

  • Primary ovarian insufficiency necessitates careful diagnosis and management due to its profound effects on reproductive capacity.
  • Fertility preservation options should be considered for at-risk individuals, including cancer patients and those with a family history of POI.
  • Addressing the long-term health consequences of estrogen deprivation is crucial for managing POI patients.